Aspect Biosystems
Member Profile
Aspect Biosystems is a biotechnology company creating bioengineered tissue therapeutics to transform how we treat disease. Aspect is applying its microfluidic 3D bioprinting technology internally to develop these advanced therapeutics and partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
Sector
Biotechnology, Medical Technology , Therapeutics
Biotechnology, Medical Technology , Therapeutics
Area of Expertise
- 3D Bioprinting
- Cardiovascular Disease
- Drug Discovery
- Immune Therapy
- Inflammatory Diseases
- Metabolic Diseases
- Neurological Diseases
- Oncology
- Regenerative Medicine
- Therapeutics
This member is looking for Academic Partnerships , Business Development , Market Opportunities
Company Stage Discovery Preclinical studies , Series A Stage
We are working On:
Aspect's microfluidic 3D bioprinting technology is currently being used by their tissue engineering R&D team to develop implantable 3D bioprinted allogeneic cell therapies for a variety of congenital and acquired diseases, including type I diabetes.
Member Profile
Biotechnology, Medical Technology , Therapeutics
Aspect Biosystems
- Website www.aspectbiosystems.com
- Phone +1 (604) 263 0502
- Email info@aspectbiosystems.com
- Address
1781 West 75th Avenue
Vancouver, BC
V6P 6P2 - Leadership Contact
Tamer Mohamed, President & CEO
No current content.